Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins

Cell Reports

Volumn 11, Issue 7, 2015, Pages 1134-1146

  Hosp, Fabian ^a,f   Vossfeldt, Hannes ^b   Heinig, Matthias ^a,c   Vasiljevic, Djordje ^a   Arumughan, Anup ^a   Wyler, Emanuel ^a   Landthaler, Markus ^a   Hubner, Norbert ^a   Wanker, Erich E ^a   Lannfelt, Lars ^d   Ingelsson, Martin ^d   Lalowski, Maciej ^e   Voigt, Aaron ^b   Selbach, Matthias ^a   Harold, Denise ^g   Abraham, Richard ^g   Hollingworth, Paul ^g   Sims, Rebecca ^g   Gerrish, Amy ^g   Chapman, Jade ^g   Russo, Giancarlo ^g   Hamshere, Marian ^g   Singh Pahwa, Jaspreet ^g   Escott Price, Valentina ^g   Dowzell, Kimberley ^g   Williams, Amy ^g   Jones, Nicola ^g   Thomas, Charlene ^g   Stretton, Alexandra ^g   Morgan, Angharad ^g   Lovestone, Simon ^h   Powell, John ^h   Proitsi, Petroula ^h   Lupton, Michelle K ^h   Brayne, Carol ⁱ   Rubinsztein, David C ^j   Gill, Michael ^k   Lawlor, Brian ^k   Lynch, Aoibhinn ^k   Morgan, Kevin ^l   Brown, Kristelle ^l   Passmore, Peter ^m   Craig, David ^m   McGuinness, Bernadette ^m   Todd, Stephen ^m   Johnston, Janet ^m   Holmes, Clive ⁿ   Mann, David ^o   David Smith, A ^p   Love, Seth ^q   Kehoe, Patrick G ^q   Hardy, John ^r   Mead, Simon ^s   Fox, Nick ^s   Rossor, Martin ^s   Collinge, John ^s   Maier, Wolfgang ^t   Jessen, Frank ^t   Heun, Reiner ^t   Schürmann, Britta ^t   Ramirez, Alfredo ^t   Becker, Tim ^ao   Herold, Christine ^ao   Lacour, André ^ao   Drichel, Dmitriy ^ao   van den Bussche, Hendrik ^u   Heuser, Isabella ^v   Kornhuber, Johannes ^w   Wiltfang, Jens ^x   Dichgans, Martin ^y   Frölich, Lutz ^z   Hampel, Harald ^aa,ab,ac   Hüll, Michael ^ad   Rujescu, Dan ^ab,ac   Goate, Alison ^ae   Kauwe, John S K ^af   Cruchaga, Carlos ^ae   Nowotny, Petra ^ae   Morris, John C ^ae   Mayo, Kevin ^ae   Livingston, Gill ^ag   Bass, Nicholas J ^ag   Gurling, Hugh ^ag   McQuillin, Andrew ^ag   Gwilliam, Rhian ^ah   Deloukas, Panagiotis ^ah   Al Chalabi, Ammar ^h   Shaw, Christopher E ^h   Singleton, Andrew B ^ai   Guerreiro, Rita ^s,ai   Mühleisen, Thomas W ^t   Nöthen, Markus M ^t   Moebus, Susanne ^aj   Jöckel, Karl Heinz ^aj   Klopp, Norman ^ak   Wichmann, H Erich ^y,ak,al   Carrasquillo, Minerva M ^am   Shane Pankratz, V ^an   Younkin, Steven G ^am   Holmans, Peter ^g   O’Donovan, Michael ^g   Owen, Michael J ^g   Williams, Julie ^g   more..

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF AACHEN MEDICAL CENTER   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

^f MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k ST JAMES S HOSPITAL   (Ireland)

^l UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^m QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

ⁿ UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^o UNIVERSITY OF MANCHESTER   (United Kingdom)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q UNIVERSITY OF BRISTOL   (United Kingdom)

^r UNIVERSITY COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY COLLEGE LONDON   (United Kingdom)

^t UNIVERSITY OF BONN   (Germany)

^u UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^v CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^w UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^x UNIVERSITY OF DUISBURG ESSEN   (Germany)

^y LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^z UNIVERSITY OF HEIDELBERG   (Germany)

^aa TRINITY COLLEGE DUBLIN   (Ireland)

^ab SORBONNE UNIVERSITÉ   (France)

^ac PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ad UNIVERSITY OF FREIBURG   (Germany)

^ae WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^af BRIGHAM YOUNG UNIVERSITY   (United States)

^ag UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ah WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^ai NATIONAL INSTITUTE ON AGING   (United States)

^aj UNIVERSITY HOSPITAL ESSEN   (Germany)

^ak INSTITUTE OF EPIDEMIOLOGY   (Germany)

^al UNIVERSITY OF MUNICH   (Germany)

^am MAYO CLINIC   (United States)

^an MAYO CLINIC   (United States)

^ao GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ATAXIN 1; HUNTINGTIN; MITOCHONDRIAL PROTEIN; PARKIN; PRESENILIN 1; PROTEIN LRPPRC; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FUNCTIONAL PROTEOMICS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IN VIVO STUDY; MITOCHONDRIAL GENE; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SPINOCEREBELLAR DEGENERATION; WILD TYPE; ANIMAL; DEGENERATIVE DISEASE; GENOME-WIDE ASSOCIATION STUDY; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; METABOLISM; PHENOTYPE; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY;

ANIMALS; CHROMATOGRAPHY, LIQUID; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOPRECIPITATION; NEURODEGENERATIVE DISEASES; PHENOTYPE; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84929709547     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.04.030     Document Type: Article

References (61)

1. Anandatheerthavarada H.K., Biswas G., Robin M.A., Avadhani N.G. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer’s amyloid precursor protein impairs mitochondrial function in neuronal cells. J.Cell Biol. 2003, 161:41-54.
2. Barabási A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 2011, 12:56-68.
3. Chatterjee S., Sang T.K., Lawless G.M., Jackson G.R. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet. 2009, 18:164-177.
4. Chen H.K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandez M.H., Aitken A., Skoulakis E.M., Orr H.T., Botas J., Zoghbi H.Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 2003, 113:457-468.
5. Choi J.Y., Ryu J.H., Kim H.S., Park S.G., Bae K.H., Kang S., Myung P.K., Cho S., Park B.C., Lee H. Co-chaperone CHIP promotes aggregation of ataxin-1. Mol. Cell. Neurosci. 2007, 34:69-79.
6. Chung M.Y., Ranum L.P., Duvick L.A., Servadio A., Zoghbi H.Y., Orr H.T. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat. Genet. 1993, 5:254-258.
7. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26:1367-1372.
8. Crespo-Barreto J., Fryer J.D., Shaw C.A., Orr H.T., Zoghbi H.Y. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet. 2010, 6:e1001021.
9. Devi L., Anandatheerthavarada H.K. Mitochondrial trafficking ofAPP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases. Biochim. Biophys. Acta 2010, 1802:11-19.
10. Devi L., Prabhu B.M., Galati D.F., Avadhani N.G., Anandatheerthavarada H.K. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunction. J.Neurosci. 2006, 26:9057-9068.
11. Dietzl G., Chen D., Schnorrer F., Su K.C., Barinova Y., Fellner M., Gasser B., Kinsey K., Oppel S., Scheiblauer S., et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 2007, 448:151-156.
12. Emamian E.S., Kaytor M.D., Duvick L.A., Zu T., Tousey S.K., Zoghbi H.Y., Clark H.B., Orr H.T. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 2003, 38:375-387.
13. Estojak J., Brent R., Golemis E.A. Correlation of two-hybrid affinity data with invitro measurements. Mol. Cell. Biol. 1995, 15:5820-5829.
14. Ewing R.M., Chu P., Elisma F., Li H., Taylor P., Climie S., McBroom-Cerajewski L., Robinson M.D., O’Connor L., Li M., et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 2007, 3:89.
15. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.C., Luchak J.M., Martinez P., Turiegano E., Benito J., Capovilla M., Skinner P.J., et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 2000, 408:101-106.
16. Gardner P.R. Aconitase: sensitive target and measure of superoxide. Methods Enzymol. 2002, 349:9-23.
17. Gingras A.C., Raught B. Beyond hairballs: The use of quantitative mass spectrometry data to understand protein-protein interactions. FEBS Lett. 2012, 586:2723-2731.
18. Gingras A.C., Gstaiger M., Raught B., Aebersold R. Analysis ofprotein complexes using mass spectrometry. Nat. Rev. Mol. Cell Biol. 2007, 8:645-654.
19. Gohil V.M., Nilsson R., Belcher-Timme C.A., Luo B., Root D.E., Mootha V.K. Mitochondrial and nuclear genomic responses to loss of LRPPRC expression. J.Biol. Chem. 2010, 285:13742-13747.
20. Guruharsha K.G., Rual J.F., Zhai B., Mintseris J., Vaidya P., Vaidya N., Beekman C., Wong C., Rhee D.Y., Cenaj O., et al. A protein complex network of Drosophila melanogaster. Cell 2011, 147:690-703.
21. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat. Genet. 2009, 41:1088-1093.
22. Heinig M., Petretto E., Wallace C., Bottolo L., Rotival M., Lu H., Li Y., Sarwar R., Langley S.R., Bauerfeind A., et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2010, 467:460-464. Cardiogenics Consortium.
23. Hirabayashi M., Inoue K., Tanaka K., Nakadate K., Ohsawa Y., Kamei Y., Popiel A.H., Sinohara A., Iwamatsu A., Kimura Y., et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 2001, 8:977-984.
24. Holden M., Deng S., Wojnowski L., Kulle B. GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studies. Bioinformatics 2008, 24:2784-2785.
25. Ideker T., Sharan R. Protein networks in disease. Genome Res. 2008, 18:644-652.
26. Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R. A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death. J.Biol. Chem. 2003, 278:51901-51910.
27. Kaltenbach L.S., Romero E., Becklin R.R., Chettier R., Bell R., Phansalkar A., Strand A., Torcassi C., Savage J., Hurlburt A., et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 2007, 3:e82.
28. Keil U., Bonert A., Marques C.A., Scherping I., Weyermann J., Strosznajder J.B., Müller-Spahn F., Haass C., Czech C., Pradier L., et al. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J.Biol. Chem. 2004, 279:50310-50320.
29. Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S., Selkoe D.J. Complex N-linked glycosylated nicastrin associates withactive gamma-secretase and undergoes tight cellular regulation. J.Biol. Chem. 2002, 277:35113-35117.
30. Lam Y.C., Bowman A.B., Jafar-Nejad P., Lim J., Richman R., Fryer J.D., Hyun E.D., Duvick L.A., Orr H.T., Botas J., Zoghbi H.Y. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006, 127:1335-1347.
31. Lee J.H., Yu W.H., Kumar A., Lee S., Mohan P.S., Peterhoff C.M., Wolfe D.M., Martinez-Vicente M., Massey A.C., Sovak G., et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010, 141:1146-1158.
32. Li H., Wetten S., Li L., St Jean P.L., Upmanyu R., Surh L., Hosford D., Barnes M.R., Briley J.D., Borrie M., et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol. 2008, 65:45-53.
33. Lim J., Crespo-Barreto J., Jafar-Nejad P., Bowman A.B., Richman R., Hill D.E., Orr H.T., Zoghbi H.Y. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 2008, 452:713-718.
34. Lin M.T., Beal M.F. Alzheimer’s APP mangles mitochondria. Nat. Med. 2006, 12:1241-1243.
35. Lin M.K., Farrer M.J. Genetics and genomics of Parkinson’s disease. Genome Med. 2014, 6:48.
36. Lundby A., Rossin E.J., Steffensen A.B., Acha M.R., Newton-Cheh C., Pfeufer A., Lynch S.N., Olesen S.P., Brunak S., Ellinor P.T., et al. Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics. Nat. Methods 2014, 11:868-874. QT Interval International GWAS Consortium (QT-IGC).
37. Malovannaya A., Lanz R.B., Jung S.Y., Bulynko Y., Le N.T., Chan D.W., Ding C., Shi Y., Yucer N., Krenciute G., et al. Analysis of the human endogenous coregulator complexome. Cell 2011, 145:787-799.
38. Marques C.A., Keil U., Bonert A., Steiner B., Haass C., Muller W.E., Eckert A. Neurotoxic mechanisms caused by the Alzheimer’s disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J.Biol. Chem. 2003, 278:28294-28302.
39. Mootha V.K., Lepage P., Miller K., Bunkenborg J., Reich M., Hjerrild M., Delmonte T., Villeneuve A., Sladek R., Xu F., et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc. Natl. Acad. Sci. USA 2003, 100:605-610.
40. Park H.J., Kim S.S., Seong Y.M., Kim K.H., Goo H.G., Yoon E.J., Min S., Kang S., Rhim H. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J.Biol. Chem. 2006, 281:34277-34287.
41. Paul F.E., Hosp F., Selbach M. Analyzing protein-protein interactions by quantitative mass spectrometry. Methods 2011, 54:387-395.
42. Querfurth H.W., LaFerla F.M. Alzheimer’s disease. N.Engl. J. Med. 2010, 362:329-344.
43. Rinner O., Mueller L.N., Hubálek M., Müller M., Gstaiger M., Aebersold R. An integrated mass spectrometric and computational framework for the analysis of protein interaction networks. Nat. Biotechnol. 2007, 25:345-352.
44. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10(Suppl):S10-S17.
45. Rossin E.J., Lage K., Raychaudhuri S., Xavier R.J., Tatar D., Benita Y., Cotsapas C., Daly M.J. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet. 2011, 7:e1001273. International Inflammatory Bowel Disease Genetics Constortium.
46. Rual J.F., Venkatesan K., Hao T., Hirozane-Kishikawa T., Dricot A., Li N., Berriz G.F., Gibbons F.D., Dreze M., Ayivi-Guedehoussou N., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005, 437:1173-1178.
47. Rubinsztein D.C., Leggo J., Coles R., Almqvist E., Biancalana V., Cassiman J.J., Chotai K., Connarty M., Crauford D., Curtis A., et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am. J. Hum. Genet. 1996, 59:16-22.
48. Ruzzenente B., Metodiev M.D., Wredenberg A., Bratic A., Park C.B., Cámara Y., Milenkovic D., Zickermann V., Wibom R., Hultenby K., et al. LRPPRC is necessary for polyadenylation and coordination of translation of mitochondrial mRNAs. EMBO J. 2012, 31:443-456.
49. Sasarman F., Brunel-Guitton C., Antonicka H., Wai T., Shoubridge E.A. LRPPRC and SLIRP interact in a ribonucleoprotein complex that regulates posttranscriptional gene expression in mitochondria. Mol. Biol. Cell 2010, 21:1315-1323. LSFC Consortium.
50. Schuster-Böckler B., Bateman A. Protein interactions in human genetic diseases. Genome Biol. 2008, 9:R9.
51. Söderberg O., Gullberg M., Jarvius M., Ridderstråle K., Leuchowius K.J., Jarvius J., Wester K., Hydbring P., Bahram F., Larsson L.G., Landegren U. Direct observation of individual endogenous protein complexes insitu by proximity ligation. Nat. Methods 2006, 3:995-1000.
52. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F.H., Goehler H., Stroedicke M., Zenkner M., Schoenherr A., Koeppen S., et al. Ahuman protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122:957-968.
53. Sterky F.H., Ruzzenente B., Gustafsson C.M., Samuelsson T., Larsson N.G. LRPPRC is a mitochondrial matrix protein that is conserved in metazoans. Biochem. Biophys. Res. Commun. 2010, 398:759-764.
54. Tanzi R.E., Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell 2005, 120:545-555.
55. Vermeulen M., Hubner N.C., Mann M. High confidence determination of specific protein-protein interactions using quantitative mass spectrometry. Curr. Opin. Biotechnol. 2008, 19:331-337.
56. Vidal M., Cusick M.E., Barabási A.L. Interactome networks and human disease. Cell 2011, 144:986-998.
57. Vossfeldt H., Butzlaff M., PrüSSing K., Ní Chárthaigh R.A., Karsten P., Lankes A., Hamm S., Simons M., Adryan B., Schulz J.B., Voigt A. Large-scale screen for modifiers of ataxin-3-derived polyglutamine-induced toxicity in Drosophila. PLoS ONE 2012, 7:e47452.
58. Wepf A., Glatter T., Schmidt A., Aebersold R., Gstaiger M. Quantitative interaction proteomics using mass spectrometry. Nat. Methods 2009, 6:203-205.
59. Williams A.J., Paulson H.L. Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci. 2008, 31:521-528.
60. Yang D.S., Tandon A., Chen F., Yu G., Yu H., Arawaka S., Hasegawa H., Duthie M., Schmidt S.D., Ramabhadran T.V., et al. Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. J.Biol. Chem. 2002, 277:28135-28142.
61. Zhong Q., Simonis N., Li Q.R., Charloteaux B., Heuze F., Klitgord N., Tam S., Yu H., Venkatesan K., Mou D., et al. Edgetic perturbation models of human inherited disorders. Mol. Syst. Biol. 2009, 5:321.